Our focus will also be on preparation for a number of other initiatives, including our future responsibility for the developments and operation of the Community’ s pharmaceutical regulatory IT strategy from 2003 onwards, the implementation of the Directive on clinical trials by 2004 at the latest and just as importantly the introduction of measures to further improve transparency of the regulatory system.